India: Haleon announces first manufacturing facility
Haleon, the consumer health company, has announced plans to establish its first manufacturing facility in India. The state-of-the-art greenfield site will be located at Pithampur in Madhya Pradesh and is spread across more than 40 acres in the Smart Industrial Park. The total investment for the strategic oral health-focused facility is approximately 2,000 crore INR, […]
UK: Haleon to open £130 million in global oral health innovation centre
Haleon, a consumer healthcare firm, has announced an investment of £130 million ($169 million) to build an innovation centre in Weybridge, UK. The new facility will reportedly feature state-of-the-art, digitally enabled research laboratories and a dedicated consumer behaviour research facility, employing 450 staff. This new facility intends to support Haleon’s oral health portfolio, including brands […]
India: Haleon to sell non-US nicotine replacement business to Dr Reddy’s
Haleon, a consumer healthcare firm, has announced it has entered into an agreement to sell its nicotine replacement therapy business outside of the US to Indian multinational pharmaceutical company Dr Reddy’s for £500 million ($633 million). The portfolio set to be acquired includes the brands Nicotinell, Nicabate, Habitrol, and Thrive, inclusive of all formats such […]
UK: Haleon sells ChapStick lip balm brand
Yellow Wood Partners, a private equity firm based in Boston, USA, has announced that its portfolio company Suave Brands has signed a binding offer to acquire the lip balm brand ChapStick from Haleon, a consumer healthcare firm, for €468 million ($519.6 million). ChapStick lip balm first debuted in the 1880s and later diversified its product […]